Outlook and opportunities for engineered environments of breast cancer dormancy
NR Richbourg, N Irakoze, H Kim, SR Peyton - Science Advances, 2024 - science.org
Dormant, disseminated breast cancer cells resist treatment and may relapse into malignant
metastases after decades of quiescence. Identifying how and why these dormant breast …
metastases after decades of quiescence. Identifying how and why these dormant breast …
Challenges and opportunities modeling the dynamic tumor matrisome
SR Peyton, MO Platt, E Cukierman - BME frontiers, 2023 - spj.science.org
We need novel strategies to target the complexity of cancer and, particularly, of metastatic
disease. As an example of this complexity, certain tissues are particularly hospitable …
disease. As an example of this complexity, certain tissues are particularly hospitable …
Addressing inequalities in breast cancer care delivery
LC Elmore, OM Fayanju - Surgical Oncology Clinics, 2023 - surgonc.theclinics.com
Breast cancer is the most common cancer diagnosed among women in the United States
and much of the world. One in eight US women will develop breast cancer in their lifetime …
and much of the world. One in eight US women will develop breast cancer in their lifetime …
Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction
SP Myers, S Bayard, AB Tadros, V Sevilimedu… - Annals of Surgical …, 2024 - Springer
Background Little is known regarding racial differences in satisfaction and quality of life
(QOL) after contralateral prophylactic mastectomy (CPM). In this study, we aim to …
(QOL) after contralateral prophylactic mastectomy (CPM). In this study, we aim to …
Racial, Lifestyle, and Healthcare Contributors to Perceived Cancer Risk among Physically Active Adolescent and Young Adult Women Aged 18–39 Years
JA Brown, MA Alalwan, S Absie, ND Korley… - International journal of …, 2023 - mdpi.com
The cancer incidence among adolescents and young adults (AYAs) has significantly
increased in recent years, but there is limited information about the factors that influence the …
increased in recent years, but there is limited information about the factors that influence the …
Aimp2 Is A Novel Prognostic Biomarker Regulates Cell Proliferation and Apoptosis in Breast Cancer
X Tuerhong, Y Cai, P Xu, Y Aihaiti - Yongsong and Xu, Peng and Aihaiti … - papers.ssrn.com
AIMP2 is a non-enzymatic factor of the aminoacyl-tRNA synthetase complex. However,
relationship between AIMP2 and breast cancer has not been reported. This study aims to …
relationship between AIMP2 and breast cancer has not been reported. This study aims to …